Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.32 - $4.83 $5.28 Million - $19.3 Million
-3,998,283 Reduced 66.19%
2,042,651 $2.82 Million
Q3 2023

Nov 14, 2023

SELL
$3.02 - $4.05 $3.76 Million - $5.04 Million
-1,244,187 Reduced 17.08%
6,040,934 $18.4 Million
Q2 2023

Aug 14, 2023

BUY
$2.79 - $5.03 $7.53 Million - $13.6 Million
2,699,339 Added 58.86%
7,285,121 $24 Million
Q1 2023

May 15, 2023

BUY
$3.14 - $8.22 $13.6 Million - $35.7 Million
4,340,915 Added 1772.76%
4,585,782 $14.6 Million
Q4 2022

Feb 14, 2023

BUY
$5.77 - $8.49 $1.41 Million - $2.08 Million
244,867 New
244,867 $1.69 Million
Q2 2018

Aug 14, 2018

SELL
$99.64 - $127.59 $12.8 Million - $16.4 Million
-128,341 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$105.8 - $150.94 $1.21 Million - $1.73 Million
-11,450 Reduced 8.19%
128,341 $21.9 Million
Q4 2017

Feb 14, 2018

BUY
$81.25 - $130.7 $11.4 Million - $18.3 Million
139,791
139,791 $24.9 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.